Indian Stock Market Update

Market Outlook

The Indian stock market benchmark indices, BSE Sensex and Nifty 50, are expected to open sharply lower on Thursday, March 19, 2026, tracking global market weakness amid concerns over rising crude oil prices. Trends in GIFT Nifty indicate a gap-down opening for the benchmark indices, with it trading around 23,240, a discount of nearly 536 points compared to the previous close of Nifty futures.

Market Performance

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

On Wednesday, the domestic market ended on a positive note, extending gains for the third consecutive session. The Nifty 50 closed above the 23,700 mark, while the Sensex climbed 633.29 points, or 0.83%, to settle at 76,704.13. The Nifty 50 rose 196.65 points, or 0.83%, to end at 23,777.80.

Stocks to Watch

On Thursday, March 19, 2026, the following stocks are likely to remain in focus:

HDFC Bank

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

• Part-time Chairman and Independent Director, Atanu Chakraborty, has stepped down with immediate effect.

Manappuram Finance

• Subsidiaries Asirvad Micro Finance and Manappuram Home Finance have secured approvals from the Reserve Bank of India for an indirect change in control and management by Bain Capital.

Vedanta

• The company's board is set to meet on Monday, March 23, to review and approve the third interim dividend on equity shares for FY26.

Nazara Technologies

• The company's wholly owned subsidiary, Nazara Technologies UK, has entered into definitive agreements to acquire a 50% controlling stake in Bluetile Games SL and BestPlay Systems SL for a total consideration of $100.3 million (₹918 crore).

UltraTech Cement

• The company has entered into an Energy Supply Agreement along with Share Subscription and Shareholders' Agreements to acquire a 26.18% stake in Sunsure Solarpark Seven Private Limited for up to ₹19.2 crore.

Zydus Lifesciences and Torrent Pharma

• The companies have entered into a licensing and supply agreement to jointly market the diabetes treatment drug Semaglutide Injection in India.

United Breweries

• The company has secured environmental clearance for its proposed greenfield brewery in Uttar Pradesh, with a planned annual production capacity of 1.3 million hectolitres.

NATCO Pharma

• The company's board is scheduled to meet on March 24 to evaluate a scheme of arrangement for the demerger of its agrochemicals business into its wholly owned subsidiary, Natco Crop Health Sciences Ltd, on a going-concern basis.